Lucerastat effect on kidney function in patients with Fabry disease: Results from the ongoing open label-extension (OLE) of the phase 3 clinical program

Molecular Genetics and Metabolism 2026

View at publisher
Authors: Eric L Wallace, Dominique Paul Germain, Peter Blattmann, Aline Frey, Kolbeinn Gudmundsson, Derralynn A. Hughes, Michael Meinel, Peter Nordbeck, Christoph Wanner
DOI: 10.1016/j.ymgme.2025.109659
Cited by: 0

Fields of Study & Subjects

Lysosomal Storage Disorders Research Glycogen Storage Diseases and Myoclonus Biomedical Research and Pathophysiology

Publication details

Journal / source
Molecular Genetics and Metabolism
Volume
147
Issue
2
Pages
109659–109659
Publication date
1 February 2026
Language
EN